NRH:quinone reductase 2: An enzyme of surprises and mysteries

Biochemical Pharmacology

Volumn 71, Issue 1-2, 2005, Pages 1-12

  Vella, Fanny ^a   Ferry, Gilles ^a   Delagrange, Philippe ^b   Boutin, Jean A ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Chloroquine; Melatonin; Molecular pharmacology; Quinone reductase 1; Quinone reductase 2; Resveratrol

Indexed keywords

CHLOROQUINE; MELATONIN; MENADIONE; MEPACRINE; OXIDOREDUCTASE INHIBITOR; QUERCETIN; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RESVERATROL;

AMINO ACID SEQUENCE; DETOXIFICATION; ENZYME ANALYSIS; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY;

EID: 28344433705     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.09.019     Document Type: Note

References (76)

1. P.F. Church, and W.A. Pryor Free-radical chemistry of cigarette smoke and its toxicological implications Environ Health Perspect 64 1985 111 126
2. T.J. Monks, R.P. Hanzlik, G.M. Cohen, D. Ross, and D.G. Graham Quinone chemistry and toxicity Toxicol Appl Pharmacol 112 1992 2 16
3. D.J. Long, and A.K. Jaiswal Mouse NRH:quinone oxidoreductase (NQO2): cloning of cDNA and gene- and tissue-specific expression Gene 252 2000 107 117
4. D.J. Long, and A.K. Jaiswal NRH:quinone oxidoreductase 2 (NQO2) Chem Biol Interact 129 2000 99 112
5. A. Brunmark, and E. Cadenas Redox and addition chemistry of quinoid compounds and its biological implications Free Radic Biol Med 7 1989 435 477
6. L. Ernster, and F. Navazio Soluble diaphorase in animal tissues Acta Chem Scand 12 1958 595 602
7. T.E. Conover, and L. Ernster Mitochondrial oxidation of extra-mitochondrial TPNH1 mediated by purified DT diaphorase Biochem Biophys Res Commun 2 1960 26 30
8. S. Liao, and H.G. Williams-Ashman Enzymatic oxidation of some non-phosphorylated derivatives of dihydronicotinamide Biochem Biophys Res Commun 4 1961 208 213
9. S. Liao, and H.G. Williams-Ashman Biochem Pharmacol 6 1961 53 54
10. S. Liao, J.T. Dulaney, and H.G. Williams-Ashman Purification and properties of a flavoprotein catalyzing the oxidation of reduced ribosyl nicotinamide J Biol Chem 237 1962 2981 2987
11. A.K. Jaiswal, P. Burnett, M. Adesnik, and O.W. McBride Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H: quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6 Biochemistry 29 1990 1899 1906
12. A.K. Jaiswal Human NAD(P)H:quinone reductase 2 J Biol Chem 269 1994 14502 14508
13. Q. Zhao, X.L. Yang, W.D. Holtzclaw, and P. Talalay Unexpected genetic and structural relationships of a long-fogotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase) Proc Natl Acad Sci USA 94 1997 1669 1674
14. Y. Zu, S. Di Bernardo, T. Yagi, and J. Hirst Redox properties of the [2Fe-2S] center in the 24 kDa (NQO2) subunit of NADH:ubiquinone oxidoreductase (complex I) Biochemistry 41 2002 10056 10069
15. A.K. Jaiswal Localization of human NQO1 gene to chromosome 16q22 and NQO2-6p25 and associated polymorphisms Pharmacogenetics 9 1999 413 418
16. M. Belinsky, and A.K. Jaiswal NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues Cancer Metastasis Rev 12 1993 103 117
17. P. Joseph, T. Xie, Y. Xu, and A.K. Jaiswal NAD(P)H:quinone oxidoreductase1 (DT-diaphorase): expression, regulation, and role in cancer Oncol Res 6 1994 525 532
18. D. Siegel, W.A. Franklin, and D. Ross Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors Clin Cancer Res 4 1998 2065 2070
19. D. Siegel, and D. Ross Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues Free Radic Biol Med 29 2000 246 253
20. A.K. Jaiswal Regulation of genes encoding NAD(P)H:quinone oxidoreductases Free Radic Biol Med 29 2000 254 262
21. A. Begleiter, and J. Fourie Induction of NQO1 in cancer cells Methods Enzymol 382 2004 320 351
22. A. Strassburg, C.P. Strassburg, M.P. Manns, and R.H. Tukey Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue Mol Pharmacol 61 2002 320 325
23. P.R. Graves, J.J. Kwiek, P. Fadden, R. Ray, K. Hardeman, and A.M. Coley Discovery of novel targets of quinoline drugs in the human purine binding proteome Mol Pharmacol 62 2002 1364 1372
24. D.J. Long, K. Iskander, A. Gaikwad, M. Arin, D.R. Roop, and R. Knox Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity J Biol Chem 277 2002 46131 46139
25. S. Dhakshinamoorthy, and A.K. Jaiswal Small maf (MafG and MafK) proteins negatively regulate antioxidant response element-mediated expression and antioxidant induction of the NAD(P)H:quinone oxidoreductase1 gene J Biol Chem 275 2000 40134 40141
26. T. Prestera, W.D. Holtzclaw, Y. Zhang, and P. Talalay Chemical and molecular regulation of enzymes that detoxify carcinogens Proc Natl Acad Sci USA 90 1993 2965 2969
27. P. Talalay, J.W. Fahey, W.D. Holtzclaw, T. Prestera, and Y. Zhang Chemoprotection against cancer phase 2 enzyme induction Toxicol Lett 82-83 1995 173 179
28. C. Xu, C.Y. Li, and A.N. Kong Induction of phase I, II and III drug metabolism/transport by xenobiotics Arch Pharm Res 28 2005 249 268
29. P. Talalay Mechanisms of induction of enzymes that protect against chemical carcinogenesis Adv Enzyme Reg 28 1989 237 250
30. H.J. Prochaska, A.B. Santamaria, and P. Talalay Rapid detection of inducers of enzymes that protect against carcinogens Proc Natl Acad Sci USA 89 1992 2394 2398
31. Y. Zhang, P. Talalay, C.G. Cho, and G.H. Posner A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure Proc Natl Acad Sci USA 89 1992 2399 2403
32. J.W. Fahey, Y. Zhang, and P. Talalay Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens Proc Natl Acad Sci USA 94 1997 10367 10372
33. J.W. Fahey, K.K. Stephenson, A.T. Dinkova-Kostova, P.A. Egner, T.W. Kensler, and P. Talalay Chlorophyll, chlorophyllin and related tetrapyrroles are significant inducers of mammalian phase 2 cytoprotective genes Carcinogenesis 26 2005 1247 1255
34. H.J. Park, Y.W. Lee, H.H. Park, Y.S. Lee, I.B. Kwon, and J.H. Yu Induction of quinone reductase by a methanol extract of Scutellaria baicalensis and its flavonoids in murine Hepa 1c1c7 cells Eur J Cancer Prev 7 1998 465 471
35. H.J. Park, Y.W. Lee, and S.K. Lee Baicalin induces NAD(P)H:quinone reductase through the transactivation of AP-1 and NF-kappaB in Hepa 1c1c7 cells Eur J Cancer Prev 13 2004 521 528
36. N.R. Bianco, L.J. Chaplin, and M.M. Montano Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage Biochem J 385 2005 279 287
37. V. Radjendirane, and A.K. Jaiswal Antioxidant response element-mediated 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induction of human NAD(P)H:quinone oxidoreductase 1 gene expression Biochem Pharmacol 58 1999 1649 1655
38. K. Wu, R. Knox, X.Z. Sun, P. Joseph, A.K. Jaiswal, and D. Zhang Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydro-nicotinamide riboside dependent oxydoreductase Arch Biochem Biophys 347 1997 221 228
39. V. Radjendirane, and A.K. Jaiswal Coordinated induction of the c-jun gene with genes encoding quinone oxidoreductases in response to xenobiotics and antioxidants Biochem Pharmacol 58 1999 597 603
40. C.E. Foster, M.A. Bianchet, P. Talalay, Q. Zhao, and L.M. Amzel Crystal structure of human quinone reductase type 2, a metalloflavoprotein Biochemistry 38 1999 9881 9886
41. R. Li, M.A. Bianchet, P. Talalay, and L.M. Amzel The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction Proc Natl Acad Sci USA 92 1995 8846 8850
42. J.J. Kwiek, Haystead TAJ, and Rudolph Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines Biochemistry 43 2004 4538 4547
43. J.A. Boutin, F. Chatelain-Egger, F. Vella, P. Delagrange, and G. Ferry Quinone reductase 2 substrate specificity and inhibition pharmacology Chem Biol Interact 151 2005 213 228
44. E. Cadenas Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism Biochem Pharmacol 49 1995 127 140
45. R.J. Knox, T.C. Jenkins, S.M. Hobbs, S. Chen, R.G. Melton, and P.J. Burke Bioactivation of 5-(azirin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy Cancer Res 60 2000 4179 4186
46. C.L. Baum, J. Selhub, and I.H. Rosenberg The hydrolysis of nicotinamide adenine dinucleotide by brush border membranes of rat intestine Biochem J 204 1982 203 207
47. C.J. Gross, and L.M. Henderson Digestion and absorption of NAD by the small intestine of the rat J Nutr 113 1983 412 420
48. T. Imai, and B.M. Anderson Metabolism of nicotinamide mononucleotide in beef liver Arch Biochem Biophys 254 1987 241 252
49. N.J. Oppenheimer NAD hydrolysis: chemical and enzymatic mechanisms Mol Cell Biochem 138 1994 245 251
50. F. Friedlos, and R.J. Knox Metabolism of NAD(P)H by blood components. Relevance to bioreductively activated prodrugs in a targeted enzyme therapy system Biochem Pharmacol 44 1992 1739 1744
51. L. Ernster, and G. Dallner Biochemical, physiological and medical aspects of ubiquinone functions Biochim Biophys Acta 1271 1995 195 204
52. A. Osyczka, C.C. Moser, F. Daldal, and P.L. Dutton Reversible redox energy coupling in electron transfer chains Nature 427 2004 607 612
53. A.M. James, Smith RAJ, and M.P. Murphy Antioxidant and prooxidant properties of mitochondrial coenzyme Q Arch Biochem Biophys 423 2004 47 56
54. J.A. Boutin, V. Audinot, G. Ferry, and P. Delagrange Molecular tools to study melatonin pathways and actions Trends Pharmacol Sci 26 2005 412 419
55. J.M. Barret, A.M. Ernould, G. Ferry, A. Genton, and J.A. Boutin Integrated system for the screening of the specificity of protein kinase inhibitors Biochem Pharmacol 46 1993 439 448
56. Mailliet F, Ferry G, Vella F, Berger S, Cogé F, Chomarat P, et al. Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme. Biochem Pharmacol, in press.
57. L. Buryanovskyy, Y. Fu, M. Boyd, Y. Ma, T.C. Hsieh, and J.M. Wu Crystal structure of quinone reductase 2 in complex with resveratrol Biochemistry 43 2004 11417 11426
58. 3 as the quinone reductase 2 J Biol Chem 275 2000 31311 31317
59. 3 FEBS Lett 578 2004 116 120
60. S. Harada, C. Fujii, A. Hayashi, and N. Ohkoshi An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductases 1 and 2 Biochem Biophys Res Commun 288 2001 887 892
61. S. Harada, H. Tachikawa, and Y. Kawanishi A possible association between an insertion/deletion polymorphism of the NQO2 gene and schizophrenia Psychiatr Genet 13 2003 205 209
62. S. Okada, F.M. Farin, P. Stapleton, H. Viernes, S.D. Quigley, and K.M. Powers No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes Neurosci Lett 375 2005 178 180
63. W. Wang, and A.K. Jaiswal Sp3 repression of polymorphic human NRH:quinone oxydoreductase 2 gene promoter Free Radic Biol Med 37 2004 1231 1243
64. V. Radjendirane, P. Joseph, Y.H. Lee, S. Kimura, A.J. Klein-Szanto, and F.J. Gonzalez Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity J Biol Chem 273 1998 7382 7389
65. K. Iskander, M. Paquet, C. Brayton, and A.K. Jaiswal Deficiency of NRH: oxidoreductase 2 increases susceptibility to 7, 12-dimethylbenz(a)anthracene and benzo(a)pyrene-induced skin carcinogenesis Cancer Res 64 2004 5925 5928
66. O. Nosjean, J.P. Nicolas, F. Klupsch, P. Delagrange, E. Canet, and J.A. Boutin Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 Biochem Pharmacol 61 2001 1369 1379
67. J.A. Boutin Indirect evidences of UDP-glucuronosyltransferase heterogeneity: how can it help purification? Drug Metab Rev 18 1987 517 551
68. N.S. Postma, E.C. Mommers, W.M. Eling, and J. Zuidema Oxidative stress in malaria: implications for rpevention and therapy Pharm World Sci 18 1996 121 128
69. Chomarat P, Cogé F, Guénin SP, Mailliet F, Vella F, Mallet C, et al. Inhibition of NRH:quinone oxido-reductase 2 activity using RNA interference in murine hippocampal HT22 cells, submitted for publication.
70. Z. Wang, T.C. Hsieh, Z. Zhang, Y. Ma, and J.M. Wu Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography Biochem Biophys Res Commun 323 2004 743 749
71. D.K. Das, M. Sato, P.S. Ray, G. Maulik, R.M. Engelman, and A.A. Bertelli Cardioprotection of red wine: role of polyphenolic antioxidants Drugs Exp Clin Res 25 1999 115 120
72. T.C. Hiseh, Z. Wang, C.V. Hamby, and J.M. Wu Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53 Biochem Biophys Res Commun 334 2005 223 230
73. R.J. Knox, P.J. Burke, S. Chen, and D.J. Kerr CB 1954: from the Walker tumor to NQO2 and VDEPT Curr Pharm Des 9 2003 2091 2104
74. G. Chung-Faye, D. Palmer, D. Anderson, J. Clark, M. Downes, and J. Baddeley enzyme prodrug therapy with a nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug: CB1954 Clin Cancer Res 7 2001 2662 2668
75. S. Grimaldi, P. Lanciano, Bertran, P. d, F. Blasco, and B. Guigliarelli Evidence for an epr-detectyable semiquinone intermediate stabilized in the membrane-bound subunit NarI of nitrate reductase A (NarGHI) from Escherichia coli Biochemistry 44 2005 1300 1308
76. D.J. Krogstad, P.H. Schlesinger, and I.Y. Gluzman Antimalarials increase vesicle pH in Plasmodium falciparum J Cell Biol 101 1985 2302 2309